PharmaSupply introduces NeedleBay insulin pen organizer
WEST PALM BEACH, Fla. — Pharma Supply earlier this week launched NeedleBay, a safe and easy method of organizing and dispensing insulin pen needles and medication.
NeedleBay provides a highly visible, unique and simple “proof of use” reminder, which eliminates the risk of missed, or excess injections and associated medications. NeedleBay has been specially designed in consultation with healthcare professionals and those with diabetes, to enable the user to deploy disposable pen needles safely and to avoid the risk of needle pick injuries.
NeedleBay allows the user to prepare in advance needles and medication for up to seven days using the NeedleBay daily modules, which can be preloaded at the beginning of the week. The NeedleBay module is compact and fits easily into a pocket or bag. The NeedleBay product line is available in multiple flexible pack sizes and colors.
NeedleBay will be available to consumers in March 2014 and will be supported with a national print and TV commercial campaign beginning in May 2014.
Tender Corp. highlights After Bite Kids insect bite treatment
LITTLETON, N.H. — Tender Corp. on Friday highlighted its After Bite Kids — an insect bite treatment specifically designed to provide relief to kids — in time for summer care planograms.
The non-stinging cream formula contains natural healing ingredients, such as baking soda, aloe vera and tea tree oil, to soothe and moisturize skin from the itching and swelling of insect bites and stings.
“After Bite is a trusted family favorite,” stated Frank Meyer, chief marketing officer at Tender Corp. “Our kids-specific formula uses Grandma’s home remedy — baking soda — for amplified instant comfort and relief of common insect bites. Parents can trust in our brand and the comfort of After Bite Kids.”
Mead Johnson expands board by one and appoints a former Ernst & Young vice chairman as a director
GLENVIEW, Ill. — Mead Johnson Nutrition on Friday expanded the size of its board from 11 to 12 members and appointed Michael Grobstein as its newest director. He is a retired vice chairman of Ernst & Young, one of the world’s largest professional services organizations.
Grobstein, 71, is currently on the board of directors of Bristol-Myers Squibb, where he is a member of the audit committee, as well as the compensation and management development committees. He also was a director of Given Imaging, where he served on several committees and was chair of the audit committee, until its recent acquisition by Covidien.
Having joined Ernst & Young in 1964, Grobstein was made a partner in 1975. He served as a vice chairman from 1984 until his retirement in 1998. During that period, he held a series of companywide leadership positions that included responsibility for accounting and auditing services; planning, marketing and industry services; and areas of international operations.
Grobstein currently serves on the boards of the Central Park Conservancy and the Peer Health Exchange.
"Mike’s knowledge of accounting, internal controls and financial reporting rules and regulations — along with his varied experience serving on the boards of several global companies — will add additional depth and strength to the broad expertise of our current board," stated James Cornelius, chairman of the Mead Johnson board.